Topological Latent Manifold Model (TLMM) v7.3 extends the validated causal-inference framework of TLMM v7.2 by introducing an Adaptive Decision Layer for personalized, counterfactually evaluated, and safety-constrained adaptive intervention while preserving the invariant Amyloid–Blood Flow (ABF) causal cascade. This release introduces: Adaptive Decision Layer for personalized intervention planning using constrained reinforcement learning (RL) and model predictive control (MPC) Counterfactual Policy Evaluation with individualized treatment effects (ITE), off-policy evaluation (IPS/SNIPS/Doubly Robust), and expected net benefit (ENB) ranking Expanded falsifiability framework (C1–C16) with a new Adaptive Intervention Validity domain High-resolution mechanistic causal network (N1–N16) with five latent confounders (U1–U5) and four hidden mediators (H1–H4) Safety and Human-in-the-Loop framework integrating explainability, clinical guardrails, clinician oversight, and continuous monitoring Adaptive intervention workflow, long-term outcome tracking, deployment readiness assessment, and clinical translational roadmap Machine-checkable graph specification (39 directed observed-node edges) with a companion graph validation script ensuring consistency between the manuscript, figures, and implementation The archive contains: Full manuscript (52 pages) Twenty publication-quality figures Companion Python graph validator README documentation All quantitative values, cohort sizes, validation metrics, and performance results are illustrative synthetic demonstrations intended to specify an evaluation and adaptive-intervention protocol. They do not represent clinical performance estimates from real patient data and do not constitute medical advice or clinical recommendations.
Koji Okino (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: